Pasar al contenido principal

PAPEL DEL RECEPTOR NUCLEAR LXR EN PROCESOS DE INFLAMACION ASOCIADA A CANCER Y METASTASIS

SAF2011-23402

•
Nombre agencia financiadora Ministerio de Ciencia e Innovación
Acrónimo agencia financiadora MICINN
Programa Programa Nacional de Proyectos de Investigación Fundamental
Subprograma Subprograma de Proyectos de Investigación Fundamental no Orientada
Convocatoria Proyectos I+D
Año convocatoria 2011
Plan Estatal 2008-2011 Plan Nacional de Investigación Científica, Desarrollo e Innovación Tecnológica
Unidad de gestión Subdirección General de Proyectos de Investigación
Centro beneficiario UNIVERSIDAD DE BARCELONA
Identificador persistente http://dx.doi.org/10.13039/501100004837

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

The Nuclear Receptor LXR Limits Bacterial Infection of Host Macrophages through a Mechanism that Impacts Cellular NAD Metabolism

  • Matalonga, Jonathan
  • Glaria, Estibaliz
  • Bresque, Mariana|||0000-0002-4570-3629
  • Escande, Carlos|||0000-0002-9611-0903
  • Carbó, José María|||0000-0001-8301-5360
  • Kiefer, Kerstin
  • Vicente, Ruben
  • León, Theresa E.
  • Beceiro, Susana
  • Pascual-García, Mónica|||0000-0002-9768-0641
  • Serret, Joan
  • Sanjurjo, Lucía|||0000-0003-4006-8010
  • Morón-Ros, Samantha|||0000-0002-6205-2442
  • Riera, Antoni|||0000-0001-7142-7675
  • Paytubi, Sonia
  • Antonio Juarez, Antonio
  • Sotillo, Fernando
  • Lindbom, Lennart
  • Caelles, Carme
  • Sarrias, Maria-Rosa|||0000-0001-6929-8069
  • Sancho, Jaime
  • Castrillo, Antonio|||0000-0002-2057-2159
  • Chini, Eduardo N.
  • Valledor, Annabel F.|||0000-0003-4232-2633
Macrophages exert potent effector functions against invading microorganisms but constitute, paradoxically, a preferential niche for many bacterial strains to replicate. Using a model of infection by Salmonella Typhimurium, we have identified a molecular mechanism regulated by the nuclear receptor LXR that limits infection of host macrophages through transcriptional activation of the multifunctional enzyme CD38. LXR agonists reduced the intracellular levels of NAD+ in a CD38-dependent manner, counteracting pathogen-induced changes in macrophage morphology and the distribution of the F-actin cytoskeleton and reducing the capability of nonopsonized Salmonella to infect macrophages.remarkably, pharmacological treatment with an LXR agonist ameliorated clinical signs associated with Salmonella infection in vivo, and these effects were dependent on CD38 expression in bonemarrow- derived cells. Altogether, this work reveals an unappreciated role for CD38 in bacterial-host cell interaction that can be pharmacologically exploited by activation of the LXR pathway.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

ApoA-I mimetic administration, but not increased apoA-I-containing HDL, inhibits tumour growth in a mouse model of inherited breast cancer

  • Cedó, Lídia|||0000-0003-4354-3411
  • Garcia León, Annabel|||0000-0003-3007-9306
  • Baila-Rueda, Lucía
  • Santos, David|||0000-0003-1157-4969
  • Grijalva, Victor
  • Martínez Cignoni, Melanie Raquel|||0000-0002-3469-7980
  • Carbó, José María|||0000-0001-8301-5360
  • Metso, Jari
  • López Vilaró, Laura|||0000-0002-5428-8017
  • Zorzano Olarte, Antonio|||0000-0002-1638-0306
  • Valledor, Annabel F.|||0000-0003-4232-2633
  • Cenarro, Ana
  • Jauhiainen, Matti|||0000-0002-3836-3785
  • Lerma Puertas, Enrique|||0000-0001-7908-2747
  • Fogelman, Alan M.
  • Reddy, Srinivasa T.
  • Escolà-Gil, Joan Carles|||0000-0001-9021-2485
  • Blanco Vaca, Francisco|||0000-0001-7380-5385
Low levels of high-density lipoprotein cholesterol (HDLc) have been associated with breast cancer risk, but several epidemiologic studies have reported contradictory results with regard to the relationship between apolipoprotein (apo) A-I and breast cancer. We aimed to determine the effects of human apoA-I overexpression and administration of specific apoA-I mimetic peptide (D-4F) on tumour progression by using mammary tumour virus-polyoma middle T-antigen transgenic (PyMT) mice as a model of inherited breast cancer. Expression of human apoA-I in the mice did not affect tumour onset and growth in PyMT transgenic mice, despite an increase in the HDLc level. In contrast, D-4F treatment significantly increased tumour latency and inhibited the development of tumours. The effects of D-4F on tumour development were independent of 27-hydroxycholesterol. However, D-4F treatment reduced the plasma oxidized low-density lipoprotein (oxLDL) levels in mice and prevented oxLDL-mediated proliferative response in human breast adenocarcinoma MCF-7 cells. In conclusion, our study shows that D-4F, but not apoA-I-containing HDL, hinders tumour growth in mice with inherited breast cancer in association with a higher protection against LDL oxidative modification.